United Arab Emirates: Pharmaceutical products
HS chapter 30 · Chemicals
Pharmaceutical products
United Arab Emirates pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$355.7 million | 95.1% |
| 3002 Human blood | US$10.8 million | 2.9% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$4.7 million | 1.2% |
| 3006 Pharmaceutical goods | US$2.1 million | 0.6% |
| 3003 Medicaments | US$479,000 | 0.1% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$134,000 | 0.0% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$157.8 million | 42.2% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$81.9 million | 21.9% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$74.6 million | 20.0% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$25.1 million | 6.7% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$10.1 million | 2.7% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$7.0 million | 1.9% |
| 300440 Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$5.9 million | 1.6% |
| 300590 Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | US$2.7 million | 0.7% |
| 300239 Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | US$2.3 million | 0.6% |
| 300510 Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | US$2.0 million | 0.5% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$3.0 billion | 69.6% |
| 3002 Human blood | US$996.1 million | 23.4% |
| 3003 Medicaments | US$145.6 million | 3.4% |
| 3006 Pharmaceutical goods | US$88.1 million | 2.1% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$58.0 million | 1.4% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$6.5 million | 0.2% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$2.2 billion | 50.5% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$699.9 million | 16.4% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$387.7 million | 9.1% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$180.2 million | 4.2% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$113.7 million | 2.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$101.3 million | 2.4% |
| 300220 Vaccines: for human medicine | US$70.3 million | 1.7% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$69.3 million | 1.6% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$68.4 million | 1.6% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$52.2 million | 1.2% |
Shares are of United Arab Emirates's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of United Arab Emirates's trade.
More United Arab Emirates products
- 27 Mineral fuels, mineral oils and products of their distillation
- 71 Natural, cultured pearls
- 85 Electrical machinery and equipment and parts thereof
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 87 Vehicles
- 76 Aluminium and articles thereof
- 39 Plastics and articles thereof
- 89 Ships, boats and floating structures
- 73 Iron or steel articles
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 72 Iron and steel
- 33 Essential oils and resinoids
United Arab Emirates pharmaceutical products: questions and answers
How much pharmaceutical products does United Arab Emirates export?
In 2024, United Arab Emirates exported US$373.9 million of pharmaceutical products (HS chapter 30), 0.1% of its total exports. That ranks it 57 of 213 exporting countries in the data.
What are United Arab Emirates' biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$355.7 million), Human blood (3002, US$10.8 million), Wadding, gauze, bandages (dressings, adhesive plasters… (3005, US$4.7 million).
How much pharmaceutical products does United Arab Emirates import?
In 2024, United Arab Emirates imported US$4.3 billion of pharmaceutical products (HS chapter 30), 1.4% of its total imports. That ranks it 31 of 226 importing countries in the data.
What are United Arab Emirates' biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$3.0 billion), Human blood (3002, US$996.1 million), Medicaments (3003, US$145.6 million).
